Board Meeting27 Oct 2026, 04:40 pm
Dr. Lal PathLabs Board Meeting on Nov 4 for Q2 Results & Interim Dividend
AI Summary
Dr. Lal PathLabs Ltd has announced that its Board of Directors will convene on November 4, 2026. The meeting's agenda includes the consideration and approval of the un-audited standalone and consolidated financial results for the Quarter and Half Year ended September 30, 2026. Additionally, the Board will evaluate the declaration of a second interim dividend, if any, for the Financial Year 2026-27. This meeting follows up on a previous intimation dated September 25, 2026.
Key Highlights
- Board meeting scheduled for November 4, 2026.
- To consider Q2 FY27 un-audited financial results.
- Will also consider declaration of 2nd interim dividend.
- Financial year 2026-27 dividend to be decided.
Price Impact
More from LALPATHLAB